These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28450239)

  • 1. An Evolutionary Search Algorithm for Covariate Models in Population Pharmacokinetic Analysis.
    Yamashita F; Fujita A; Sasa Y; Higuchi Y; Tsuda M; Hashida M
    J Pharm Sci; 2017 Sep; 106(9):2407-2411. PubMed ID: 28450239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building.
    Sherer EA; Sale ME; Pollock BG; Belani CP; Egorin MJ; Ivy PS; Lieberman JA; Manuck SB; Marder SR; Muldoon MF; Scher HI; Solit DB; Bies RR
    J Pharmacokinet Pharmacodyn; 2012 Aug; 39(4):393-414. PubMed ID: 22767341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjusted adaptive Lasso for covariate model-building in nonlinear mixed-effect pharmacokinetic models.
    Haem E; Harling K; Ayatollahi SM; Zare N; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2017 Feb; 44(1):55-66. PubMed ID: 28144841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of correlation on covariate selection in linear and nonlinear mixed effect models.
    Bonate PL
    Pharm Stat; 2017 Jan; 16(1):45-54. PubMed ID: 27580760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of clinical irrelevance criteria in covariate model building with application to dofetilide pharmacokinetic data.
    Tunblad K; Lindbom L; McFadyen L; Jonsson EN; Marshall S; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2008 Oct; 35(5):503-26. PubMed ID: 19011957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lasso--a novel method for predictive covariate model building in nonlinear mixed effects models.
    Ribbing J; Nyberg J; Caster O; Jonsson EN
    J Pharmacokinet Pharmacodyn; 2007 Aug; 34(4):485-517. PubMed ID: 17516152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of pharmacokinetic studies for latent covariates.
    Lagishetty CV; Coulter CV; Duffull SB
    J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):87-97. PubMed ID: 22161222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel method based on unbiased correlations tests for covariate selection in nonlinear mixed effects models: The COSSAC approach.
    Ayral G; Si Abdallah JF; Magnard C; Chauvin J
    CPT Pharmacometrics Syst Pharmacol; 2021 Apr; 10(4):318-329. PubMed ID: 33755345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonparametric goodness-of-fit testing for parametric covariate models in pharmacometric analyses.
    Hartung N; Wahl M; Rastogi A; Huisinga W
    CPT Pharmacometrics Syst Pharmacol; 2021 Jun; 10(6):564-576. PubMed ID: 33755347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended least squares (ELS) for pharmacokinetic models.
    Metzler CM
    J Pharm Sci; 1987 Jul; 76(7):565-71. PubMed ID: 3668820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fast method for testing covariates in population PK/PD Models.
    Khandelwal A; Harling K; Jonsson EN; Hooker AC; Karlsson MO
    AAPS J; 2011 Sep; 13(3):464-72. PubMed ID: 21725709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated covariate model building within NONMEM.
    Jonsson EN; Karlsson MO
    Pharm Res; 1998 Sep; 15(9):1463-8. PubMed ID: 9755901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM.
    Jonsson EN; Karlsson MO
    Comput Methods Programs Biomed; 1999 Jan; 58(1):51-64. PubMed ID: 10195646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous confidence bands for nonlinear regression models with application to population pharmacokinetic analyses.
    Gsteiger S; Bretz F; Liu W
    J Biopharm Stat; 2011 Jul; 21(4):708-25. PubMed ID: 21516565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Power, selection bias and predictive performance of the Population Pharmacokinetic Covariate Model.
    Ribbing J; Jonsson EN
    J Pharmacokinet Pharmacodyn; 2004 Apr; 31(2):109-34. PubMed ID: 15379381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis.
    Wählby U; Jonsson EN; Karlsson MO
    AAPS PharmSci; 2002; 4(4):E27. PubMed ID: 12645999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Models for time-varying covariates in population pharmacokinetic-pharmacodynamic analysis.
    Wählby U; Thomson AH; Milligan PA; Karlsson MO
    Br J Clin Pharmacol; 2004 Oct; 58(4):367-77. PubMed ID: 15373929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fuzzy least squares for identification of individual pharmacokinetic parameters.
    Seng KY; Nestorov I; Vicini P
    IEEE Trans Biomed Eng; 2009 Dec; 56(12):2796-805. PubMed ID: 19695981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further Evaluation of Covariate Analysis using Empirical Bayes Estimates in Population Pharmacokinetics: the Perception of Shrinkage and Likelihood Ratio Test.
    Xu XS; Yuan M; Yang H; Feng Y; Xu J; Pinheiro J
    AAPS J; 2017 Jan; 19(1):264-273. PubMed ID: 27761720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics.
    Mentré F; Mallet A; Steimer JL
    Biometrics; 1988 Sep; 44(3):673-83. PubMed ID: 3203126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.